{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:50:52Z","timestamp":1781945452737,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22078281"],"award-info":[{"award-number":["22078281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22208286"],"award-info":[{"award-number":["22208286"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.talanta.2026.129370","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:01:21Z","timestamp":1767916881000},"page":"129370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Twin-column recycling chromatography with step solvent gradient and heart-cut technique for separation and purification of trace drug impurities"],"prefix":"10.1016","volume":"302","author":[{"given":"Guangxia","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarong","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2026.129370_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2024.105715","article-title":"Safety assessment of drug impurities for patient safety: a comprehensive review","volume":"153","author":"Liu","year":"2024","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.talanta.2026.129370_bib2","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1080\/10408347.2022.2032587","article-title":"An overview of advances in the chromatography of drugs impurity profiling","volume":"53","author":"Alsaeedy","year":"2022","journal-title":"Crit. Rev. Anal. Chem."},{"issue":"2","key":"10.1016\/j.talanta.2026.129370_bib3","first-page":"76","article-title":"A quality concept for impurities during drug development - use of the hyphenated LC-MS technique, PHARMACEUTICAL SCIENCE & TECHNOLOGY","volume":"1","author":"Ermer","year":"1998","journal-title":"Today Off."},{"issue":"2","key":"10.1016\/j.talanta.2026.129370_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5530\/ijpi.14.2.37","article-title":"Impurities in drug substance - an overview of ICH Q3A, Q3C and M7 guidelines","volume":"14","author":"Dsouza","year":"2024","journal-title":"Int. J. Pharm. Invest."},{"issue":"4","key":"10.1016\/j.talanta.2026.129370_bib5","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1007\/s12247-021-09607-9","article-title":"A comprehensive review on assessment and key control strategies for impurities in drug development with a special emphasis on post-marketing surveillance","volume":"17","author":"Tapkir","year":"2022","journal-title":"J. Pharm. Innov."},{"issue":"18","key":"10.1016\/j.talanta.2026.129370_bib6","doi-asserted-by":"crossref","first-page":"15445","DOI":"10.1021\/acssuschemeng.9b02948","article-title":"Green development of polymeric dummy artificial receptors with affinity for amide-based pharmaceutical impurities","volume":"7","author":"Viveiros","year":"2019","journal-title":"ACS Sustain. Chem. Eng."},{"key":"10.1016\/j.talanta.2026.129370_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.trac.2017.10.025","article-title":"Impurity investigations by phases of drug and product development","volume":"101","author":"Olsen","year":"2018","journal-title":"TrAC, Trends Anal. Chem."},{"issue":"21","key":"10.1016\/j.talanta.2026.129370_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202404945","article-title":"An unusual, methylated impurity in diethyl sulphate: identification, structure elucidation, and linkage with N-methyl impurity of an active pharmaceutical ingredient","volume":"10","author":"Bhale","year":"2025","journal-title":"ChemistrySelect"},{"issue":"1","key":"10.1016\/j.talanta.2026.129370_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/157341211794708749","article-title":"A review on need and importance of impurity profiling","volume":"7","author":"Nagpal","year":"2011","journal-title":"Curr. Pharmaceut. Anal."},{"issue":"1","key":"10.1016\/j.talanta.2026.129370_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/jssc.202300712","article-title":"Comparison of different extraction methods of active ingredients of Chinese medicine and natural products","volume":"47","author":"Li","year":"2024","journal-title":"J. Separ. Sci."},{"key":"10.1016\/j.talanta.2026.129370_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106979","article-title":"Challenges in the identification and quantification of an unknown impurity in chenodeoxycholic acid drug substance","volume":"205","author":"Bouwhuis","year":"2025","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"10","key":"10.1016\/j.talanta.2026.129370_bib12","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1021\/jasms.5c00105","article-title":"Absolute quantitation of coeluting impurities in peptide drugs using high resolution mass spectrometry: glucagon a case study in pharmaceutical development","volume":"36","author":"Kodidasu","year":"2025","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"9","key":"10.1016\/j.talanta.2026.129370_bib13","article-title":"Development of a stability-indicating RP-HPLC method for the quantification of tolperisone hydrochloride and diclofenac sodium impurities in drug substances and in combination: implementation of analytical quality by design and degradation kinetics","volume":"8","author":"Mohite","year":"2025","journal-title":"Sep. Sci."},{"issue":"3","key":"10.1016\/j.talanta.2026.129370_bib14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0731-7085(89)80093-7","article-title":"The determination of chlorpromazine, related impurities and degradation products in pharmaceutical dosage forms","volume":"7","author":"Chagonda","year":"1989","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.talanta.2026.129370_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13065-025-01500-7","article-title":"Green chromatographic approach to determine methocarbamol, aspirin and their related impurities in their combined pharmaceutical formulation and human plasma: with computational evaluation","volume":"19","author":"Bassuoni","year":"2025","journal-title":"BMC Chem."},{"key":"10.1016\/j.talanta.2026.129370_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejps.2019.03.003","article-title":"The identification and chromatographic separation of a new highly analogous impurity of the active pharmaceutical ingredient icatibant","volume":"132","author":"Lajin","year":"2019","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.talanta.2026.129370_bib17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2174\/0115734110320008240628090739","article-title":"Chromatography chronicles: unveiling the power of reversed-phase high-performance thin layer chromatography in pharmaceutical analysis","volume":"21","author":"Pandya","year":"2024","journal-title":"Curr. Anal. Chem."},{"issue":"13","key":"10.1016\/j.talanta.2026.129370_bib18","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2174\/13895575110091223","article-title":"Application of chromatography technology in the separation of active components from nature derived drugs","volume":"10","author":"Zhao","year":"2010","journal-title":"Mini Rev. Med. Chem."},{"issue":"12","key":"10.1016\/j.talanta.2026.129370_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/jssc.202201023","article-title":"An overview of recent progress in multiple dual-mode counter-current chromatography","volume":"46","author":"Zhang","year":"2023","journal-title":"J. Separ. Sci."},{"issue":"1","key":"10.1016\/j.talanta.2026.129370_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/aic.18597","article-title":"Three-step integrated process for isolation and purification of impurities in drug substance by recycling chromatography","volume":"71","author":"Jin","year":"2025","journal-title":"AIChE J."}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914026000238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914026000238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:19:53Z","timestamp":1781943593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914026000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":20,"alternative-id":["S0039914026000238"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2026.129370","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Twin-column recycling chromatography with step solvent gradient and heart-cut technique for separation and purification of trace drug impurities","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2026.129370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129370"}}